glipizide

FDA Drug Profile — Glucotrol XL

Drug Details

Generic Name
glipizide
Brand Names
Glucotrol XL
Application Number
NDA020329
Sponsor
Roerig
NDC Codes
6
Dosage Forms
TABLET, EXTENDED RELEASE, POWDER
Routes
ORAL
Active Ingredients
GLIPIZIDE

Indications and Usage

1 INDICATIONS AND USAGE Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 ) Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis ( 1 ) 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.